Home » Newsletters » BioWorld Asia

BioWorld Asia

March 11, 1998

View Archived Issues

Transgène Seeks FFr420M In IPOs In France, US

bi03111998c.html

Trinity Turns Loss To Revenue; Buyouts Helped Bottom Line

Center Studying Vaccines For Rheumatic Fever, Malaria

Cantab's Revenues Double; R&D Program Set To Expand

Glaxo, Thallia Teaming Up For Microalgae-Based Drugs

PPL Expresses Blood-Clotting Agent In Transgenic Sheep Milk

Chinese Study Horse Drug As Human AIDS Vaccine

Amgen Supporting Cell Therapy Laboratory In France

EU 'Closely Follows' Ethics Of Gene-Based Diagnostics

Chiroscience Spins Off DNA Analysis Subsidiary

Agen Rebuffs A$16M Takeover Move By Biotech International

EU May Lend Support To Added Worldwide Rules On Cloning

British Biotech Losses 'In Line With Plan'

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...